作者：
Joseph P,Casazza [1]
;
Evan M,Cale [2]
;
Sandeep,Narpala [2]
;
Galina V,Yamshchikov [2]
;
Emily E,Coates [2]
;
Cynthia S,Hendel [2]
;
Laura,Novik [2]
;
LaSonji A,Holman [2]
;
Alicia T,Widge [2]
;
Preeti,Apte [2]
;
Ingelise,Gordon [2]
;
Martin R,Gaudinski [2]
;
Michelle,Conan-Cibotti [2]
;
Bob C,Lin [2]
;
Martha C,Nason [3]
;
Olga,Trofymenko [2]
;
Shinyi,Telscher [2]
;
Sarah H,Plummer [2]
;
Diane,Wycuff [2]
;
William C,Adams [2]
;
Janardan P,Pandey [4]
;
Adrian,McDermott [2]
;
Mario,Roederer [2]
;
Avery N,Sukienik [2]
;
Sijy,O'Dell [2]
;
Jason G,Gall [2]
;
Britta,Flach [2]
;
Travis L,Terry [2]
;
Misook,Choe [2]
;
Wei,Shi [2]
;
Xuejun,Chen [2]
;
Florence,Kaltovich [2]
;
Kevin O,Saunders [5]
;
Judy A,Stein [2]
;
Nicole A,Doria-Rose [2]
;
Richard M,Schwartz [2]
;
Alejandro B,Balazs [6]
;
David,Baltimore [7]
;
Gary J,Nabel [8]
;
Richard A,Koup [9]
;
Barney S,Graham [2]
;
Julie E,Ledgerwood [2]
;
John R,Mascola [2]
;
VRC 603 Study Team [2]
作者单位：
Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. jcasazza@mail.nih.gov.
[1]
Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
[2]
Biostatistics Research Branch Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
[3]
Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, SC, USA.
[4]
Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.
[5]
Vaxart, Inc., South San Francisco, CA, USA.
[6]
Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA.
[7]
Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA.
[8]
ModeX Therapeutics, Natick, MA, USA.
[9]
DOI
10.1038/s41591-022-01762-x
PMID
35411076
发布时间
2023-11-09
换一批
换一批
